RGC stock recently surged to $11.35, reflecting a 71% increase, driven by strong momentum in the drug sector and speculative interest. The bullish view anticipates further upside if the stock sustains its momentum, with a potential target of $13-$14 based on technical resistance levels. However, the rally appears speculative, and caution is advised as volatility remains high.